How does ChatGPT work? And its creator? Are you ready to cooperate with the vaccine?

Published Date: 16 Feb 2023

Chatbots have shields to control misinformation, but it will continue to be a game.

Read Full News

Latest News

New Tool Detects Alcohol in Steatotic Liver Disease

A simple new index may quantify the role of alcohol in steatotic liver disease without expensive testing.

The Fascinating Phenomenon That Is Your Brain on Exercise

A cascade of beneficial effects hits the brain during exercise — with new data on strength training. Helping your patients understand it can be a powerful motivator.

Facilitated Cascade Genetic Testing: A New Standard of Care?

A clinician-led approach boosts genetic testing among relatives of people with newly detected pathogenic variants — and could help close a gap in hereditary cancer prevention.

Positive Age Beliefs Linked to Functional Gains

Using Health and Retirement Study data, 31.9% show cognitive gains, and 28% improve gait speed over follow-up — findings that challenge the assumption that decline is inevitable.

Can We Agree on Fetal Growth Restriction Criteria?

Major international and national guidelines on fetal growth restriction (FGR) converge on surveillance and preterm interventions but diverge substantially on how FGR is defined.

Pollution, Poverty, May Age the Brain as Much as AD

Combined and cumulative physical and social environmental exposure may be more closely linked to brain aging than a clinical diagnosis such as Alzheimer’s Disease or MCI, a new study shows.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

A simple new index may quantify the role of alcohol in steatotic liver disease without expensive testing.

A cascade of beneficial effects hits the brain during exercise — with new data on strength training. Helping your patients understand it can be a powerful motivator.

A clinician-led approach boosts genetic testing among relatives of people with newly detected pathogenic variants — and could help close a gap in hereditary cancer prevention.

Using Health and Retirement Study data, 31.9% show cognitive gains, and 28% improve gait speed over follow-up — findings that challenge the assumption that decline is inevitable.

Major international and national guidelines on fetal growth restriction (FGR) converge on surveillance and preterm interventions but diverge substantially on how FGR is defined.

Combined and cumulative physical and social environmental exposure may be more closely linked to brain aging than a clinical diagnosis such as Alzheimer’s Disease or MCI, a new study shows.

News All Time

CAR T-Cell Therapy Tied to Better Survival in Relapsed LBCL

A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs historical care for relapsed or refractory LBCL.

Medical Use of Cannabis Poses Risks in Adolescents

Adolescents who use cannabis on a medical recommendation report more frequent use of cannabis and other substances than peers who use the drug without a medical recommendation.

TB Today: Short-Course, Long Problems

Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease persists — medicine alone cannot end TB.

AI Chatbot Prescribing Psychiatric Meds Raises Red Flags

A pilot program that will allow a chatbot to authorize select psychiatric prescription refills while state regulators suspend enforcement of some licensure rules is raising legal and safety concerns.

AI and Medical Errors: Who Takes the Blame Now?

AI use in clinical care raises unresolved liability questions, with clinicians retaining responsibility as evolving technology and legal frameworks continue to blur accountability.

PrEP Use ‘Strikingly Low’ in People Younger Than 25

More training may be needed for health professionals, including pediatricians, to increase prescribing to teens.

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

How the Gulf Crisis Is Reaching Europe’s Pharmacies

Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.

The Flaws in the New HHS Nutrition Education Initiative

Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.

Acute Severe Ulcerative Colitis: 10 Risks in Older Adults

Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.

Antidepressant Promising for Methamphetamine Addiction

There are no approved medications for methamphetamine use disorder, but phase 3 trial results suggest the generic antidepressant mirtazapine may offer modest but significant reductions in use.

Proximity to Nuclear Plants Linked to Cancer Mortality

A US ecologic study finds higher cancer mortality in counties closer to nuclear plants, but results reflect association and require cautious clinical interpretation.

Modern Breast Radiation Shows Minimal Heart Risks

Modern techniques have greatly reduced the heart disease risks historically tied to radiotherapy for left-sided breast cancer, a large cohort study suggests.

Social Risks Linked to Higher Spending on Healthcare

Certain social risk factors are linked to higher costs of healthcare among patients.

Depression, Delirium May Signal Supranuclear Palsy Risk

Depression, delirium, gastrointestinal disorders, and heavy alcohol consumption are modifiable risk factors for progressive supranuclear palsy, a new study shows.

Hypnotic Therapy Tied to Reduced Spinal Cord Injury Pain

Hypnotic cognitive therapy is associated with greater reductions in chronic pain and depression than usual care in patients with spinal cord injury, a new study shows.

Recommended News For You

Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

Cancer detection recovered following pandemic disruptions

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

Best foot forward—chemo care should include podiatry, say researchers

Recommended Articles For You

Polyposis Syndrome: Causes, Symptoms, and Treatment Options 

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education? 

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia 

The Benefits of Understanding Haptoglobin High: What You Need to Know 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

2.

High numbers of rural patients cross state lines for cancer care

3.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

4.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

5.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

1.

Understanding SVR Normal Range: A Guide to Achieving Optimal Health

2.

Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA

3.

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care

4.

Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options

5.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

4.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

5.

A New Era in Managing Cancer-Associated Thrombosis

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot